HOME > ARCHIVE
ARCHIVE
- DIAGNOSTIC NEWS IN BRIEF
April 21, 2003
- Hisamitsu: Consolidated Sales Up 0.7% to \70 Bil.
April 21, 2003
- WORLD NEWS IN BRIEF
April 21, 2003
- Chugai to Be Ranked No. 4 after Integration with Nippon Roche: Mr Nagayama
April 21, 2003
- The 26th General Assembly of the Japan Medical Congress
April 21, 2003
- Makers, Wholesalers Differ on Cost-sharing for Safety Measures on Bio-derived Products
April 21, 2003
- Flat-sum System Gives Greater Reimbursement Points: Kagoshima Univ. Simulation
April 14, 2003
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
April 14, 2003
- REGULATORY NEWS IN BRIEF
April 14, 2003
- EDEN Brings Together Int'l Research on Clinical Pharmacology: Prof. Cohen
April 14, 2003
- Rohto Develops New Zinc Sulfate Eye Drops against UV Radiation
April 14, 2003
- WORLD NEWS IN BRIEF
April 14, 2003
- Genox Research to Start Technology Transfer
April 14, 2003
- 2 Influenza Drugs Faced Shortage This Season
April 14, 2003
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
April 14, 2003
- Kissei Licenses Mitiglinide to Choongwae of South Korea
April 14, 2003
- Matsumotokiyoshi's Profit Forecasts Revised Upward by Security Analysts
April 14, 2003
- Chugai to Focus on Proper Use Following Launch of Xeloda
April 14, 2003
- Sugi Pharmacy: Sales, Profits Increase Remarkably
April 14, 2003
- Toho Reorganizes with Kyoso Mirai Group
April 14, 2003
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
